These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7200608)

  • 1. Collateral sensitivity to methotrexate and dichloromethotrexate of cultured lymphocytic leukemia L1210 cells resistant to 6-mercaptopurine.
    Wilkoff LJ; Dulmadge EA
    Proc Soc Exp Biol Med; 1982 May; 170(1):78-81. PubMed ID: 7200608
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
    Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
    Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage.
    Browman GP; Csullog GW
    Biochem Pharmacol; 1981 Apr; 30(8):869-74. PubMed ID: 7195709
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of bis(6-mercaptopurine-9-beta-D-ribofuranoside)-5',5"-phosphate and its butyryl derivative on mouse leukaemia L1210 and a 6-mercaptopurine-resistant subline in culture.
    Tidd DM; Johnston HP; Gibson I
    Biochem Pharmacol; 1982 Sep; 31(18):2903-12. PubMed ID: 6897189
    [No Abstract]   [Full Text] [Related]  

  • 5. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 6. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of antineoplastic agents on the respiratory activity of murine lymphocytic leukemia L1210.
    Goodman MT; Ackerman GA
    Experientia; 1973 Sep; 29(9):1124-6. PubMed ID: 4795618
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate analogs. 4.7-Methyl derivatives of methotrexate and dichloromethotrexate. A new synthesis and some biological studies.
    Rosowsky A; Chen KK
    J Med Chem; 1974 Dec; 17(12):1308-11. PubMed ID: 4214928
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of L1210 mouse leukemia cells in vitro.
    Hutchison DJ; Ittensohn OL; Bjerregaard MR
    Exp Cell Res; 1966 Apr; 42(1):157-70. PubMed ID: 5929562
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
    Johnston HP; Hawley P; White SE; Gibson I; Tidd DM
    Br J Cancer; 1985 Apr; 51(4):505-14. PubMed ID: 3838480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.
    Hoshino A; Albrecht AM; Hutchison DJ
    Cancer Res; 1966 May; 26(5):974-8. PubMed ID: 5934806
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic changes associated with resistance to methotrexate and 6-mercaptopurine in L1210 ascites lymphoma.
    Calman NS; Eng B; Slater LM; Wallerstein H
    J Natl Cancer Inst; 1974 Mar; 52(3):997-8. PubMed ID: 4826575
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of resistance to methotrexate in L1210 murine leukemia by uracil.
    Wallerstein H; Slater LM; Eng B; Calman N
    Blood; 1971 Nov; 38(5):648-56. PubMed ID: 5094586
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate analogues. 25. Chemical and biological studies on the gamma-tert-butyl esters of methotrexate and aminopterin.
    Rosowsky A; Freisheim JH; Bader H; Forsch RA; Susten SS; Cucchi CA; Frei E
    J Med Chem; 1985 May; 28(5):660-7. PubMed ID: 3872941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.